help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on February 5, 2003, doi:10.1164/rccm.200209-1113OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200209-1113OCv1
167/10/1355    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koguchi, Y.
Right arrow Articles by Saito, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koguchi, Y.
Right arrow Articles by Saito, A.
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 1355-1359, (2003)
© 2003 American Thoracic Society

High Plasma Osteopontin Level and Its Relationship with Interleukin-12–mediated Type 1 T Helper Cell Response in Tuberculosis

Yoshinobu Koguchi, Kazuyoshi Kawakami, Kaori Uezu, Kiyoyasu Fukushima, Sigeyuki Kon, Masahiro Maeda, Atsushi Nakamoto, Isoko Owan, Mutsuo Kuba, Norifumi Kudeken, Masato Azuma, Satomi Yara, Takashi Shinzato, Futoshi Higa, Masao Tateyama, Jun-Ichi Kadota, Hiroshi Mukae, Shigeru Kohno, Toshimitsu Uede and Atsushi Saito

First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa; Nagasaki Prefecture Tarami Hospital; Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki; Division of Molecular Immunology, Research Section of Molecular Pathogenesis, Institute for Genetic Medicine, Hokkaido University, Sapporo; Immuno-Biological Laboratories Co., Ltd., Gunma; National Okinawa Hospital, Ginowan; and Second Department of Internal Medicine, Oita Medical College, Oita, Japan

Correspondence and requests for reprints should be addressed to Dr. Kazuyoshi Kawakami, M.D., Ph.D., First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903–0215, Japan. E-mail: kawakami{at}med.u-ryukyu.ac.jp

Osteopontin (OPN, also known as Eta-1), a noncollagenous matrix protein produced by macrophages and T lymphocytes, is expressed in granulomatous lesions caused by Mycobacterium tuberculosis infection. In the present study, we compared plasma concentrations of OPN in patients with active pulmonary tuberculosis with those of healthy control subjects and patients with sarcoidosis, another disease associated with granuloma formation. Plasma OPN levels were significantly higher in patients with tuberculosis (n = 48) than in control subjects (n = 34) and patients with sarcoidosis (n = 20). OPN levels correlated well with severity of pulmonary tuberculosis, as indicated by the size of lung lesions on chest X-ray films. Furthermore, chemotherapy resulted in a significant fall in plasma OPN levels. In patients with tuberculosis, plasma OPN concentrations correlated significantly with those of interleukin (IL)-12. In vitro experiments showed that OPN production by peripheral blood mononuclear cells infected with Mycobacterium bovis bacillus Calmette–Guérin preceded the synthesis of IL-12 and interferon-{gamma} and that the neutralizing anti-OPN monoclonal antibody significantly reduced the production of IL-12 and interferon-{gamma}. Our results suggest that OPN may be involved in the pathologic process associated with active pulmonary tuberculosis by inducing IL-12–mediated type 1 T helper cell responses.

Key Words: osteopontin • interleukin-12 • tuberculosis • sarcoidosis • Mycobacterium bovis bacillus Calmette–Guérin




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
B.-D. Grigoriu, A. Scherpereel, P. Devos, B. Chahine, M. Letourneux, P. Lebailly, M. Gregoire, H. Porte, M.-C. Copin, and P. Lassalle
Utility of Osteopontin and Serum Mesothelin in Malignant Pleural Mesothelioma Diagnosis and Prognosis Assessment
Clin. Cancer Res., May 15, 2007; 13(10): 2928 - 2935.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
J. Sodek, A. P. Batista Da Silva, and R. Zohar
Osteopontin and mucosal protection.
J. Dent. Res., May 1, 2006; 85(5): 404 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Z. Hu, D. Lin, J. Yuan, T. Xiao, H. Zhang, W. Sun, N. Han, Y. Ma, X. Di, M. Gao, et al.
Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non-Small Cell Lung Cancer
Clin. Cancer Res., July 1, 2005; 11(13): 4646 - 4652.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
K. Kawamura, K. Iyonaga, H. Ichiyasu, J. Nagano, M. Suga, and Y. Sasaki
Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation
Clin. Vaccine Immunol., January 1, 2005; 12(1): 206 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Tuberculosis, Lung Infections, Interstitial Lung Disease, Social Issues and Journalology in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 288 - 300.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society